SPRR3, a novel miR‑338‑3p target, regulates the malignant progression of clear cell renal cell carcinoma in vitro via the PI3K/Akt signaling pathway
Author:
Affiliation:
1. Department of Nephrology, The Second Hospital of Jilin University, Changchun, Jilin 130041, P.R. China
2. College of Food Engineering, Jilin Engineering Normal University, Changchun, Jilin 130052, P.R. China
Publisher
Spandidos Publications
Subject
Cancer Research,Immunology and Microbiology (miscellaneous),General Medicine
Reference28 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Updated European association of urology guidelines: Recommendations for the treatment of first-line metastatic clear cell renal cancer;Powles;Eur Urol,2018
3. EAU guidelines on renal cell carcinoma: 2014 update;Ljungberg;Eur Urol,2015
4. Upregulation of SPRR3 promotes colorectal tumorigenesis;Cho;Mol Med,2010
5. Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer;Kim;Breast Cancer Res Treat,2012
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3